Phagocyte extracellular traps in children with neutrophilic airway inflammation

Paul T King1,2, Lovisa Dousha1,2, Nadeene Clarke3,4

  • 1Monash Lung and Sleep, Monash Medical Centre, Melbourne, Australia.

ERJ Open Research
|June 24, 2021
PubMed

Insights

Childhood lung infections show significant neutrophil extracellular traps (NETs) and macrophage extracellular traps (METs). Treatments like deoxyribonuclease 1 and alpha1-antitrypsin can reduce these inflammatory markers in children.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pediatrics

Background:

  • Childhood lung infections feature neutrophilic airway inflammation and elevated proteases like neutrophil elastase (NE).
  • Neutrophil extracellular traps (NETs) and macrophage extracellular traps (METs) are implicated in inflammatory processes but their role in pediatric lung infections is not fully understood.

Purpose of the Study:

  • To quantify NET and MET expression in children with cystic fibrosis and chronic cough.
  • To investigate the effects of deoxyribonuclease 1 (DNase 1) and alpha1-antitrypsin (AAT) on NET/MET formation and neutrophil elastase activity.

Main Methods:

  • Studied 76 children undergoing bronchoscopy, measuring NETs, METs, and NE activity in bronchoalveolar lavage (BAL) samples.
  • Utilized confocal microscopy and functional assays to analyze extracellular traps and protease activity.
  • Examined the in vitro effects of DNase 1 and AAT on NET/MET expression and NE activity.

Main Results:

  • Both cystic fibrosis and non-cystic fibrosis groups exhibited significant airway neutrophilia with prominent NETs and co-expressed NE.
  • NET expression correlated with detectable NE activity.
  • DNase 1 reduced NET/MET expression but increased NE activity, while the combination of AAT and DNase 1 effectively reduced NE activity.

Conclusions:

  • Symptomatic children, with or without cystic fibrosis, display prominent extracellular trap formation.
  • This innate inflammatory response can be modulated by combining DNase 1 and AAT, suggesting therapeutic potential.